tradingkey.logo

Omnicell Inc

OMCL
查看详细走势图
45.300USD
-0.620-1.35%
收盘 12/31, 16:00美东报价延迟15分钟
2.03B总市值
104.80市盈率 TTM

Omnicell Inc

45.300
-0.620-1.35%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.35%

5天

-0.59%

1月

+24.08%

6月

+54.08%

今年开始到现在

+1.75%

1年

+4.57%

查看详细走势图

TradingKey Omnicell Inc股票评分

单位: USD 更新时间: 2025-12-30

操作建议

Omnicell Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名9/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价48.17。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Omnicell Inc评分

相关信息

行业排名
9 / 207
全市场排名
56 / 4560
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 8 位分析师
买入
评级
48.167
目标均价
+10.60%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Omnicell Inc亮点

亮点风险
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
利润高增长
公司净利润处于行业前列,最新年度总收入1.11B美元
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值106.23,处于3年历史高位
机构减仓
最新机构持股48.76M股,环比减少13.49%
巴罗·汉利持仓
明星投资者巴罗·汉利持仓,最新持仓市值100.00

Omnicell Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Omnicell Inc简介

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
公司代码OMCL
公司Omnicell Inc
CEOLipps (Randall A)
网址https://www.omnicell.com/

常见问题

Omnicell Inc(OMCL)的当前股价是多少?

Omnicell Inc(OMCL)的当前股价是 45.300。

Omnicell Inc的股票代码是什么?

Omnicell Inc的股票代码是OMCL。

Omnicell Inc股票的52周最高点是多少?

Omnicell Inc股票的52周最高点是47.690。

Omnicell Inc股票的52周最低点是多少?

Omnicell Inc股票的52周最低点是22.660。

Omnicell Inc的市值是多少?

Omnicell Inc的市值是2.03B。

Omnicell Inc的净利润是多少?

Omnicell Inc的净利润为12.53M。

现在Omnicell Inc(OMCL)的股票是买入、持有还是卖出?

根据分析师评级,Omnicell Inc(OMCL)的总体评级为买入,目标价格为48.167。

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是多少

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是0.432。
KeyAI